Zantac Linked to Esophageal Cancer

There have been an abundance of cancer lawsuits filed against Zantac (Ranitidine) since it was petitioned for recall in September 2019. The company that conducts routine tests for the popular heartburn/antacid drug found that it contains unsafe levels of the known carcinogen NDMA, or N-nitrosodimethylamine. This has led to widespread recall by companies that produce the drug, as well as the removal of these products from pharmacy shelves across the nation.


Zantac users who have developed cancer are filing lawsuits against the drug’s manufacturers on several counts including Negligence, Strict Liability - Design Defect, and Strict Liability - Failure to warn. These cases state that the drug companies were responsible for testing products and had a duty to report the true “character, quality, and nature” of the drug.


A Virginia woman named Deborah Haskins developed esophageal cancer after taking at least one 75 mg dosage of Zantac per day since 2015. Her case asserted that her cancer was contracted “as a direct and proximate result of ingesting Zantac.”


There have been other suits in the past several months requesting compensation for similar damages of esophageal cancer. Donald Boland of Florida was diagnosed with esophageal cancer after taking Zantac three times a day since 2002. New Jersey resident Michael DeLuccia started using Zantac in 2001 and was subsequently diagnosed with esophageal cancer in 2017. They are both filing a lawsuit against the drug manufacturers.


What Additional Types of Cancers are being Linked to using Zantac?

Zantac and similar drugs have been used (and marketed as safe) since Ranitidine was introduced to the market in the 1980s. Many individuals who suffer from heartburn, indigestion, acid reflux and similar symptoms have been treating their discomfort with the drug for years or even decades.


Zantac may be tied to various types of cancers, since the formation of NDMA following the ingestion of Zantac (Ranitidine) may occur throughout different areas of the body.


Those unfortunate enough to have developed nay of the following cancers due to regular and prolonged usage of Zantac or similar heartburn medications may be eligible to receive compensation:

  • Bladder cancer

  • Stomach cancer

  • Liver cancer

  • Colorectal cancer

  • Kidney/renal cancer

  • Leukemia

  • Multiple Myeloma

  • Non-Hodgkin's Lymphoma

  • Pancreatic cancer

  • Prostate cancer

  • Small intestine cancer


How Can We Help?

If you or a loved one has developed one of the above cancers after using Zantac (ranitidine), make sure to contact us at Kwartler Manus. Our dedicated attorneys have experience representing clients in similar cases. By filing/joining a mass tort claim against Zantac, you may be able to get compensation for your damages and protect others from future threats. Our attorneys will be by your side to help you navigate this complex process with ease and help you win the money you deserve.


Don’t hesitate to pursue the compensation you deserve to make up for these pharmaceutical companies’ mistakes. Contact us today to schedule a free consultation and learn your rights.

Categories

Put Us On Your Side

  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.